GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Revvity RVTY · USD

Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States

S&P 500

Compare

160.72

+3.62%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Revvity annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 28 Dec 2025, filed on 24 Feb 2026.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$2.86bn$2.76bn$2.75bn$3.31bn$3.83bn
Operating income$356.6m$410.5m$399.5m$781.1m$1.34bn
Net income$241.7m$295.8m−$118.4m$569.2m$943.2m
Free cash flow$508.3m$541.7m$9.9m$594.2m$1.31bn
Total assets$12.17bn$12.39bn$13.56bn$14.13bn$15.00bn
Shareholders' equity$7.25bn$7.67bn$7.87bn$7.38bn$7.14bn

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.